Skip to main content
Erschienen in: American Journal of Clinical Dermatology 5/2016

01.10.2016 | Review Article

Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies

verfasst von: Jeremy Udkoff, Philip R. Cohen

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Amyopathic dermatomyositis is a rare, idiopathic, connective tissue disease that presents with dermatologic lesions of classic dermatomyositis but lacks the myopathy of this disease. Cutaneous manifestations may include Gottron’s sign, heliotrope rash, and characteristic patterns of poikiloderma. There is a substantial risk for developing interstitial lung disease or malignancy in patients with amyopathic dermatomyositis. A literature review of amyopathic dermatomyositis was performed using the PubMed medical database. The key features of amyopathic dermatomyositis, including autoantibodies, clinical presentation and dermatologic manifestations, epidemiology, history, associated malignancies, management, and pathogenesis, are summarized in this review. Cancer (solid tumor) (73/79, 89 %) and hematologic malignancies (9/79, 11 %) were reported in 79 patients, with three patients having more than one malignancy. In addition, there were six patients with amyopathic dermatomyositis who had tumor of unknown primary, and eight patients with cancer-associated amyopathic dermatomyositis for whom no additional details were provided. From the group of 73 tumors for whom primary origin and sex were available, malignancy of the genitourinary organs (24/73, 33 %), aerorespiratory organs (15/73, 21 %), and breast (14/73, 19 %) were the most commonly observed solid organ tumors. Tumors of the genitourinary organs (15/48, 31 %) and breast (14/48, 29 %) were the most frequent neoplasms in women, accounting for 29 of 48 (60 %) cancers, with the most common sites being breast (14/48, 29 %), ovary (8/48, 17 %), and cervix or uterus (5/48, 10 %). In men, tumors of the aerorespiratory (9/25, 36 %) and genitourinary (9/25, 36 %) tracts were the most common neoplasms, accounting for 72 % (18/25) of cancers; the most common sites of primary malignancy were nasopharyngeal (6/25, 24 %), bladder (4/25, 16 %), and either colorectal, lung or prostate cancer (three cancers each, 12 %). In summary, the search for an undiagnosed associated malignancy in patients with amyopathic dermatomyositis should focus towards the organs most frequently affected. Similar to classic dermatomyositis, ovarian and nasopharyngeal cancers are also common in amyopathic dermatomyositis. However, in contrast to lung cancer, which is the most frequent malignancy associated with classic dermatomyositis, breast cancer was the most common type of malignancy reported in patients with amyopathic dermatomyosotis.
Literatur
1.
Zurück zum Zitat Ghazi E, Sontheimer RD, Werth VP. The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol. 2013;31(1):128–34.PubMed Ghazi E, Sontheimer RD, Werth VP. The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol. 2013;31(1):128–34.PubMed
2.
Zurück zum Zitat Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.PubMedCrossRef Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.PubMedCrossRef
3.
Zurück zum Zitat Rockerbie NR, Woo TY, Callen JP, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 1989;20(4):629–32.PubMedCrossRef Rockerbie NR, Woo TY, Callen JP, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 1989;20(4):629–32.PubMedCrossRef
4.
Zurück zum Zitat Reeder MJ, Wetter DA, Li X, Davis M. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Dermatol Clin. 2010;146(1):26–30. Reeder MJ, Wetter DA, Li X, Davis M. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Dermatol Clin. 2010;146(1):26–30.
5.
Zurück zum Zitat Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597–613.PubMedCrossRef Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597–613.PubMedCrossRef
6.
Zurück zum Zitat Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol. 2007;57(6):937–43.PubMedCrossRef Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol. 2007;57(6):937–43.PubMedCrossRef
7.
Zurück zum Zitat Bailey EE, Fiorentino DF. Amyopathic dermatomyositis: definitions, diagnosis, and management. Curr Rheumatol Rep. 2014;16(12):465.PubMedCrossRef Bailey EE, Fiorentino DF. Amyopathic dermatomyositis: definitions, diagnosis, and management. Curr Rheumatol Rep. 2014;16(12):465.PubMedCrossRef
8.
Zurück zum Zitat Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24(6 Pt 1):959–66.PubMedCrossRef Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24(6 Pt 1):959–66.PubMedCrossRef
9.
Zurück zum Zitat El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46(4):560–5.PubMedCrossRef El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46(4):560–5.PubMedCrossRef
10.
Zurück zum Zitat Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003;61(3):288–9.PubMedCrossRef Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003;61(3):288–9.PubMedCrossRef
11.
Zurück zum Zitat van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316–21.PubMedCrossRef van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316–21.PubMedCrossRef
12.
Zurück zum Zitat Bronner IM, Linssen WHJP, van der Meulen MFG, Hoogendijk JE, de Visser M. Polymyositis: an ongoing discussion about a disease entity. Arch Neurol. 2004;61(1):132–5.PubMedCrossRef Bronner IM, Linssen WHJP, van der Meulen MFG, Hoogendijk JE, de Visser M. Polymyositis: an ongoing discussion about a disease entity. Arch Neurol. 2004;61(1):132–5.PubMedCrossRef
13.
Zurück zum Zitat Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD. A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol. 2007;157(4):637–44.PubMedCrossRef Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD. A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol. 2007;157(4):637–44.PubMedCrossRef
14.
Zurück zum Zitat Ortigosa LCM, dos Reis VMS. Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo. Brazil. An Bras Dermatol. 2014;89(5):719–27.PubMedCrossRef Ortigosa LCM, dos Reis VMS. Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo. Brazil. An Bras Dermatol. 2014;89(5):719–27.PubMedCrossRef
15.
Zurück zum Zitat Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7.PubMedCrossRef Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7.PubMedCrossRef
16.
Zurück zum Zitat Callen JP. Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep. 2010;12(3):192–7.PubMedCrossRef Callen JP. Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep. 2010;12(3):192–7.PubMedCrossRef
17.
Zurück zum Zitat Takahashi Y, Murota H, Tarutani M, Sano S, Okinaga T, Tominaga K, et al. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis? Allergol Int. 2010;59(4):425–8.PubMedCrossRef Takahashi Y, Murota H, Tarutani M, Sano S, Okinaga T, Tominaga K, et al. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis? Allergol Int. 2010;59(4):425–8.PubMedCrossRef
18.
19.
Zurück zum Zitat Eichenfield DZ, Paravar T. Zebra stripes in dermatomyositis: case report and review of flagellate erythema-associated dermatomyositis. J Eur Acad Dermatol Venereol. 2016. doi:10.1111/jdv.13582.PubMed Eichenfield DZ, Paravar T. Zebra stripes in dermatomyositis: case report and review of flagellate erythema-associated dermatomyositis. J Eur Acad Dermatol Venereol. 2016. doi:10.​1111/​jdv.​13582.PubMed
20.
Zurück zum Zitat Pau-Charles I, Moreno PJ, Ortiz-Ibáñez K, Lucero MC, Garcia-Herrera A, Espinosa G, et al. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy. J Eur Acad Dermatol Venereol. 2014;28(8):1097–102.PubMedCrossRef Pau-Charles I, Moreno PJ, Ortiz-Ibáñez K, Lucero MC, Garcia-Herrera A, Espinosa G, et al. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy. J Eur Acad Dermatol Venereol. 2014;28(8):1097–102.PubMedCrossRef
21.
Zurück zum Zitat Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013;14(4):291–313.PubMedCrossRef Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013;14(4):291–313.PubMedCrossRef
22.
Zurück zum Zitat Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677–85.PubMedCrossRef Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677–85.PubMedCrossRef
23.
Zurück zum Zitat van der Kooi AJ, de Visser M. Idiopathic inflammatory myopathies. Handb Clin Neurol. 2014;119:495–512.PubMedCrossRef van der Kooi AJ, de Visser M. Idiopathic inflammatory myopathies. Handb Clin Neurol. 2014;119:495–512.PubMedCrossRef
24.
Zurück zum Zitat Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464–74.PubMedCrossRef Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464–74.PubMedCrossRef
25.
Zurück zum Zitat Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006;45(Suppl 4):iv18–21. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006;45(Suppl 4):iv18–21.
26.
Zurück zum Zitat Kubo N, Sawayama Y, Okada K, Nakagawa Y, Asou Y, Nabeshima S, et al. A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation [in Japanese]. Ryūmachi. 2002;42(4):676–81.PubMed Kubo N, Sawayama Y, Okada K, Nakagawa Y, Asou Y, Nabeshima S, et al. A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation [in Japanese]. Ryūmachi. 2002;42(4):676–81.PubMed
27.
Zurück zum Zitat Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38(10):973–9.PubMedCrossRef Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38(10):973–9.PubMedCrossRef
28.
Zurück zum Zitat Nofal A, El-Din ES. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? Int J Dermatol. 2012;51(5):535–41.PubMedCrossRef Nofal A, El-Din ES. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? Int J Dermatol. 2012;51(5):535–41.PubMedCrossRef
29.
30.
Zurück zum Zitat Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol. 2013;2013:509354.PubMedPubMedCentralCrossRef Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol. 2013;2013:509354.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. DM4-Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.PubMedCrossRef Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. DM4-Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.PubMedCrossRef
32.
33.
Zurück zum Zitat Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363–7.PubMedCrossRef Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363–7.PubMedCrossRef
34.
Zurück zum Zitat Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969–71.PubMedCrossRef Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969–71.PubMedCrossRef
35.
Zurück zum Zitat Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009;31(1):61–7.PubMedCrossRef Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009;31(1):61–7.PubMedCrossRef
36.
Zurück zum Zitat Tansley S, Gunawardena H. The evolving spectrum of polymyositis and dermatomyositis—moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol. 2014;47(3):264–73.PubMedCrossRef Tansley S, Gunawardena H. The evolving spectrum of polymyositis and dermatomyositis—moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol. 2014;47(3):264–73.PubMedCrossRef
37.
Zurück zum Zitat Chinoy H, Lamb JA, Ollier WER, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011;13(3):216.PubMedPubMedCentralCrossRef Chinoy H, Lamb JA, Ollier WER, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011;13(3):216.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, Trallero-Araguás E, Balada E, Vilardell-Tarrés M, et al. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis. 2012;71(6):993–6.PubMedCrossRef Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, Trallero-Araguás E, Balada E, Vilardell-Tarrés M, et al. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis. 2012;71(6):993–6.PubMedCrossRef
39.
Zurück zum Zitat Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22(6):639–43.PubMedCrossRef Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22(6):639–43.PubMedCrossRef
40.
Zurück zum Zitat Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147(4):391–8.PubMedCrossRef Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147(4):391–8.PubMedCrossRef
41.
Zurück zum Zitat Muro Y, Ishikawa A, Sugiura K, Akiyama M. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies. Rheumatology (Oxford). 2012;51(8):1508–13.CrossRef Muro Y, Ishikawa A, Sugiura K, Akiyama M. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies. Rheumatology (Oxford). 2012;51(8):1508–13.CrossRef
42.
Zurück zum Zitat Ogawa M, Sugiura K, Yokota K, Muro Y, Akiyama M. Anti-transcription intermediary factor 1-γ antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer. J Eur Acad Dermatol Venereol. 2016;30(2):373–5.PubMedCrossRef Ogawa M, Sugiura K, Yokota K, Muro Y, Akiyama M. Anti-transcription intermediary factor 1-γ antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer. J Eur Acad Dermatol Venereol. 2016;30(2):373–5.PubMedCrossRef
43.
Zurück zum Zitat Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for dermatomyositis. American academy of dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):824–9.PubMed Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for dermatomyositis. American academy of dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):824–9.PubMed
44.
Zurück zum Zitat Lam WWM, Chan H, Chan YL, Fung JWK, So NMC, Metreweli C. MR imaging in amyopathic dermatomyositis. Acta Radiol. 1999;40(1):69–72.PubMedCrossRef Lam WWM, Chan H, Chan YL, Fung JWK, So NMC, Metreweli C. MR imaging in amyopathic dermatomyositis. Acta Radiol. 1999;40(1):69–72.PubMedCrossRef
45.
Zurück zum Zitat Stonecipher MR, Jorizzo JL, White WL, Walker FO, Prichard E. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis? J Am Acad Dermatol. 1993;28(6):951–6.PubMedCrossRef Stonecipher MR, Jorizzo JL, White WL, Walker FO, Prichard E. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis? J Am Acad Dermatol. 1993;28(6):951–6.PubMedCrossRef
46.
Zurück zum Zitat Dawkins MA, Jorizzo JL, Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38(3):397–404.PubMedCrossRef Dawkins MA, Jorizzo JL, Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38(3):397–404.PubMedCrossRef
47.
Zurück zum Zitat Cosnes A, Amaudric F, Gherardi R, Verroust J, Wechsler J, Revuz J, et al. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 1995;131(12):1381–5.PubMedCrossRef Cosnes A, Amaudric F, Gherardi R, Verroust J, Wechsler J, Revuz J, et al. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 1995;131(12):1381–5.PubMedCrossRef
48.
Zurück zum Zitat Goyal S, Nousari HC. Paraneoplastic amyopathic dermatomyositis associated with breast cancer recurrence. J Am Acad Dermatol. 1999;41(5 Pt 2):874–5.PubMedCrossRef Goyal S, Nousari HC. Paraneoplastic amyopathic dermatomyositis associated with breast cancer recurrence. J Am Acad Dermatol. 1999;41(5 Pt 2):874–5.PubMedCrossRef
49.
Zurück zum Zitat Mebazaa A, Boussen H, Nouira R, Gamoudi A, Rahal K, Kamoun MR, et al. Dermatomyositis and breast cancer: a multicenter Tunisian retrospective study of 13 cases. La Tunisie médicale. 2011;89(1):18–22.PubMed Mebazaa A, Boussen H, Nouira R, Gamoudi A, Rahal K, Kamoun MR, et al. Dermatomyositis and breast cancer: a multicenter Tunisian retrospective study of 13 cases. La Tunisie médicale. 2011;89(1):18–22.PubMed
50.
Zurück zum Zitat Yasar S, Gurleyik G, Sabuncuoglu Y, Aktekin A, Yasar B, Serdar ZA. Paget’s disease of the breast in a patient with amyopathic dermatomyositis. Case Rep Med. 2012;2012(C):1–4. Yasar S, Gurleyik G, Sabuncuoglu Y, Aktekin A, Yasar B, Serdar ZA. Paget’s disease of the breast in a patient with amyopathic dermatomyositis. Case Rep Med. 2012;2012(C):1–4.
51.
Zurück zum Zitat Blanes M, Bañuls J, Yuste A, Adrover E, Pascual JC, Pastor N, et al. Amyopathic dermatomyositis associated with a recurrence of breast cancer. Actas Dermo-Sifiliográficas. 2005;96(5):299–302.PubMedCrossRef Blanes M, Bañuls J, Yuste A, Adrover E, Pascual JC, Pastor N, et al. Amyopathic dermatomyositis associated with a recurrence of breast cancer. Actas Dermo-Sifiliográficas. 2005;96(5):299–302.PubMedCrossRef
52.
Zurück zum Zitat Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Clin Rheumatol. 2007;26(7):1198–200.PubMedCrossRef Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Clin Rheumatol. 2007;26(7):1198–200.PubMedCrossRef
53.
Zurück zum Zitat Pusceddu V, Frau B, Guerzoni D, Catani G, Murgia M, Murru M, et al. Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer. Breast J. 2008;14(6):591–2.PubMedCrossRef Pusceddu V, Frau B, Guerzoni D, Catani G, Murgia M, Murru M, et al. Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer. Breast J. 2008;14(6):591–2.PubMedCrossRef
54.
Zurück zum Zitat Park SH, Kum YS, Kim KC, Choe JY, Park SH, Kim SK. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29(10):1231–5.PubMedCrossRef Park SH, Kum YS, Kim KC, Choe JY, Park SH, Kim SK. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29(10):1231–5.PubMedCrossRef
55.
Zurück zum Zitat Fung JWK, Chan HL, Lam WWM. Amyopathic dermatomyositis in Hong Kong—association with nasopharyngeal carcinoma. Int J Dermatol. 1998;37(9):659–63.PubMedCrossRef Fung JWK, Chan HL, Lam WWM. Amyopathic dermatomyositis in Hong Kong—association with nasopharyngeal carcinoma. Int J Dermatol. 1998;37(9):659–63.PubMedCrossRef
56.
Zurück zum Zitat Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore. 2000;29(2):219–23.PubMed Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore. 2000;29(2):219–23.PubMed
57.
Zurück zum Zitat Whitmore SE, Watson R, Rosenshein NB, Provost TT. Dermatomyositis sine myositis: association with malignancy. J Rheumatol. 1996;23(1):101–5.PubMed Whitmore SE, Watson R, Rosenshein NB, Provost TT. Dermatomyositis sine myositis: association with malignancy. J Rheumatol. 1996;23(1):101–5.PubMed
58.
Zurück zum Zitat Ee HL, Ng PPL, Tan SH. Exacerbation of amyopathic dermatomyositis in Orientals: a high alert for nasopharyngeal carcinoma. Australas J Dermatol. 2004;45(1):77–8.PubMedCrossRef Ee HL, Ng PPL, Tan SH. Exacerbation of amyopathic dermatomyositis in Orientals: a high alert for nasopharyngeal carcinoma. Australas J Dermatol. 2004;45(1):77–8.PubMedCrossRef
59.
Zurück zum Zitat Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009;28(8):979–84.PubMedCrossRef Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009;28(8):979–84.PubMedCrossRef
60.
Zurück zum Zitat Orme CM, Zhou LH, Lazic T. Clinically amyopathic dermatomyositis in a patient with an extramedullary plasmacytoma of the tongue. J Dermatol. 2012;39(7):656–7.PubMedCrossRef Orme CM, Zhou LH, Lazic T. Clinically amyopathic dermatomyositis in a patient with an extramedullary plasmacytoma of the tongue. J Dermatol. 2012;39(7):656–7.PubMedCrossRef
61.
Zurück zum Zitat Galimberti F, Li Y, Fernandez AP. Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort. Br J Dermatol. 2016;174(1):158–64.PubMedCrossRef Galimberti F, Li Y, Fernandez AP. Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort. Br J Dermatol. 2016;174(1):158–64.PubMedCrossRef
62.
Zurück zum Zitat Langan SM, O’Briain S, Barnes L. Dermatomyositis associated with angiotropic lymphoma. Clin Exp Dermatol. 2003;28(6):597–9.PubMedCrossRef Langan SM, O’Briain S, Barnes L. Dermatomyositis associated with angiotropic lymphoma. Clin Exp Dermatol. 2003;28(6):597–9.PubMedCrossRef
63.
Zurück zum Zitat Osman Y, Narita M, Kishi K, Fujiwara H, Fukuda T, Koike T, et al. Case report: amyopathic dermatomyositis associated with transformed malignant lymphoma. Am J Med Sci. 1996;311(5):240–2.PubMedCrossRef Osman Y, Narita M, Kishi K, Fujiwara H, Fukuda T, Koike T, et al. Case report: amyopathic dermatomyositis associated with transformed malignant lymphoma. Am J Med Sci. 1996;311(5):240–2.PubMedCrossRef
64.
Zurück zum Zitat Ledwich LJ, Olenginski TP. A rare lymphoma in a patient with amyopathic dermatomyositis. Am J Clin Dermatol. 2010;11(2):151–5.PubMedCrossRef Ledwich LJ, Olenginski TP. A rare lymphoma in a patient with amyopathic dermatomyositis. Am J Clin Dermatol. 2010;11(2):151–5.PubMedCrossRef
65.
Zurück zum Zitat Requena C, Alfaro A, Traves V, Nagore E, Llombart B, Serra C, et al. Paraneoplastic dermatomyositis: a study of 12 cases. Actas dermo-sifiliográficas. 2014;105(7):675–82.PubMedCrossRef Requena C, Alfaro A, Traves V, Nagore E, Llombart B, Serra C, et al. Paraneoplastic dermatomyositis: a study of 12 cases. Actas dermo-sifiliográficas. 2014;105(7):675–82.PubMedCrossRef
66.
Zurück zum Zitat Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, et al. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus. 2015;4:240.PubMedPubMedCentralCrossRef Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, et al. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus. 2015;4:240.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Uchida A, Sugihara M, Ito S, Nowatari T, Kunikata T, Suzuki T, et al. Ovarian cancer with swelling of the right upper arm, amyopathic dermatomyositis, and elevated serum KL-6. Nihon Naika Gakkai Zasshi. 2006;95(4):742–4.PubMedCrossRef Uchida A, Sugihara M, Ito S, Nowatari T, Kunikata T, Suzuki T, et al. Ovarian cancer with swelling of the right upper arm, amyopathic dermatomyositis, and elevated serum KL-6. Nihon Naika Gakkai Zasshi. 2006;95(4):742–4.PubMedCrossRef
68.
Zurück zum Zitat Seidler AM, Wasserman DI, González-Serva A, Konnikov N. Amyopathic dermatomyositis resembling stasis dermatitis. J Am Acad Dermatol. 2008;59(3):515–8.PubMedCrossRef Seidler AM, Wasserman DI, González-Serva A, Konnikov N. Amyopathic dermatomyositis resembling stasis dermatitis. J Am Acad Dermatol. 2008;59(3):515–8.PubMedCrossRef
69.
Zurück zum Zitat Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21(2):178–83.PubMedCrossRef Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21(2):178–83.PubMedCrossRef
70.
Zurück zum Zitat Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, et al. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res. 2014;2014:290797.PubMedPubMedCentralCrossRef Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, et al. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res. 2014;2014:290797.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Kita Y. Post-operative acute exacerbation of interstitial pneumonea associated with amyopathic dermatomyositis. Kyobu Geka. 2010;63(7):546–9.PubMed Kita Y. Post-operative acute exacerbation of interstitial pneumonea associated with amyopathic dermatomyositis. Kyobu Geka. 2010;63(7):546–9.PubMed
72.
Zurück zum Zitat Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38(8):1636–43.PubMedCrossRef Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38(8):1636–43.PubMedCrossRef
73.
Zurück zum Zitat Russ BW, English JC, King DH, Halbach DP. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder. Cutis. 1999;63(2):73–6.PubMed Russ BW, English JC, King DH, Halbach DP. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder. Cutis. 1999;63(2):73–6.PubMed
74.
Zurück zum Zitat Olhoffer IH, Carroll C, Watsky K. Dermatomyositis sine myositis presenting with calcinosis universalis. Br J Dermatol. 1999;141(2):365–6.PubMedCrossRef Olhoffer IH, Carroll C, Watsky K. Dermatomyositis sine myositis presenting with calcinosis universalis. Br J Dermatol. 1999;141(2):365–6.PubMedCrossRef
75.
Zurück zum Zitat Apaydin R, Gül U, Bahadir S, Siviloglu C, Ofluoglu I. Dermatomyositis without muscle weakness associated with transitional cell carcinoma of the bladder. J Eur Acad Dermatol Venereol. 2002;16(2):172–4.PubMedCrossRef Apaydin R, Gül U, Bahadir S, Siviloglu C, Ofluoglu I. Dermatomyositis without muscle weakness associated with transitional cell carcinoma of the bladder. J Eur Acad Dermatol Venereol. 2002;16(2):172–4.PubMedCrossRef
76.
Zurück zum Zitat Dunn CL, James WD. The role of magnetic resonance imaging in the diagnostic evaluation of dermatomyositis. Arch Dermatol. 1993;129(9):1104–6.PubMedCrossRef Dunn CL, James WD. The role of magnetic resonance imaging in the diagnostic evaluation of dermatomyositis. Arch Dermatol. 1993;129(9):1104–6.PubMedCrossRef
77.
Zurück zum Zitat Finger DR, Dunn CL, Gilliland WR, James WD. Amyopathic dermatomyositis associated with malignancy. Int J Dermatol. 1996;35(9):663–4.PubMedCrossRef Finger DR, Dunn CL, Gilliland WR, James WD. Amyopathic dermatomyositis associated with malignancy. Int J Dermatol. 1996;35(9):663–4.PubMedCrossRef
78.
Zurück zum Zitat Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, et al. Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today. 2000;30(3):302–4.PubMedCrossRef Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, et al. Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today. 2000;30(3):302–4.PubMedCrossRef
79.
Zurück zum Zitat Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56(4):255–86.CrossRef Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56(4):255–86.CrossRef
80.
Zurück zum Zitat Celebi S, Gül A, Kamali S, Inanc M, Ocal L, Aral O, et al. Amyopathic dermatomyositis associated with cervical cancer. Clin Rheumatol. 2001;20(6):438–40.PubMedCrossRef Celebi S, Gül A, Kamali S, Inanc M, Ocal L, Aral O, et al. Amyopathic dermatomyositis associated with cervical cancer. Clin Rheumatol. 2001;20(6):438–40.PubMedCrossRef
81.
Zurück zum Zitat Kikuchi K, Seto Y, Matsubara T, Yamada K, Tamaki K. Amyopathic dermatomyositis associated with esophageal cancer. Int J Dermatol. 2008;47(3):310–1.PubMedCrossRef Kikuchi K, Seto Y, Matsubara T, Yamada K, Tamaki K. Amyopathic dermatomyositis associated with esophageal cancer. Int J Dermatol. 2008;47(3):310–1.PubMedCrossRef
82.
Zurück zum Zitat Nogi S, Hashimoto A, Iwata K, Futami H, Takaoka H, Arinuma Y, et al. Case of immunosuppressant-resistant amyopathic dermatomyositis with rapidly progressive interstitial pneumonia ameliorated after resection of gastric cancer. Japanese J Clin Immunol. 2012;35(3):188–93.CrossRef Nogi S, Hashimoto A, Iwata K, Futami H, Takaoka H, Arinuma Y, et al. Case of immunosuppressant-resistant amyopathic dermatomyositis with rapidly progressive interstitial pneumonia ameliorated after resection of gastric cancer. Japanese J Clin Immunol. 2012;35(3):188–93.CrossRef
83.
Zurück zum Zitat Villers A, Lami M-C, Filoche P, Milinkevitch S, Goujon J-M, Guillet G. Regression of primary melanoma with metastases associated with amyopathic dermatomyositis. Ann Dermatol Venereol. 2006;133(6–7):573–6.PubMedCrossRef Villers A, Lami M-C, Filoche P, Milinkevitch S, Goujon J-M, Guillet G. Regression of primary melanoma with metastases associated with amyopathic dermatomyositis. Ann Dermatol Venereol. 2006;133(6–7):573–6.PubMedCrossRef
84.
Zurück zum Zitat Norrenberg S, Gangji V, Del Marmol V, Soyfoo MS. Diffuse muscular pain, skin tightening, and nodular regenerative hyperplasia revealing paraneoplastic amyopathic dermatomyositis due to testicular cancer. Case Rep Rheumatol. 2012;2012:1–4.CrossRef Norrenberg S, Gangji V, Del Marmol V, Soyfoo MS. Diffuse muscular pain, skin tightening, and nodular regenerative hyperplasia revealing paraneoplastic amyopathic dermatomyositis due to testicular cancer. Case Rep Rheumatol. 2012;2012:1–4.CrossRef
85.
Zurück zum Zitat Molina-Ruiz AM, Romero F, Carrasco L, Feltes F, Haro R, Requena L. Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association? Clin Exp Dermatol. 2015;40(8):887–90.PubMedCrossRef Molina-Ruiz AM, Romero F, Carrasco L, Feltes F, Haro R, Requena L. Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association? Clin Exp Dermatol. 2015;40(8):887–90.PubMedCrossRef
86.
Zurück zum Zitat Ritchie SA, Kobayashi T, Sperling L. Amyopathic necrotizing dermatomyositis secondary to an underlying malignancy: a case report and review of the literature. Cutis. 2008;82(6):407–13.PubMed Ritchie SA, Kobayashi T, Sperling L. Amyopathic necrotizing dermatomyositis secondary to an underlying malignancy: a case report and review of the literature. Cutis. 2008;82(6):407–13.PubMed
87.
Zurück zum Zitat Pérez-Pérez LC, Suárez-Amor O, Sánchez-Aguilar D, Ginarte M, Pereiro M, Toribio J. Clinically-amyopathic dermatomyositis: presentation of three cases. Actas Dermo-Sifiliográficas. 2005;96(5):295–8.PubMedCrossRef Pérez-Pérez LC, Suárez-Amor O, Sánchez-Aguilar D, Ginarte M, Pereiro M, Toribio J. Clinically-amyopathic dermatomyositis: presentation of three cases. Actas Dermo-Sifiliográficas. 2005;96(5):295–8.PubMedCrossRef
Metadaten
Titel
Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies
verfasst von
Jeremy Udkoff
Philip R. Cohen
Publikationsdatum
01.10.2016
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2016
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0199-z

Weitere Artikel der Ausgabe 5/2016

American Journal of Clinical Dermatology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.